Bråtveit M, Helle K B
Acta Physiol Scand. 1984 Jul;121(3):269-76. doi: 10.1111/j.1748-1716.1984.tb07456.x.
Exogenous VIP caused a concentration dependent inhibition of the spontaneous mechanical activity in the isolated rat mesenteric-portal vein preparation via a mechanism which was completely independent of the propranolol-blocked beta-adrenoceptor, of high K+ in the medium and of exogenous bovine pancreatic polypeptide, neurotensin and opioids. The potency of VIP (pD2 = 7.52 +/- 0.18, n = 6) was about 30 times higher than that of isoprenaline in the atropine and phentolamine-blocked preparation. The isoprenaline inhibition was mediated via a beta 2-type of adrenoceptor with low apparent affinity for noradrenaline (intrinsic activity (alpha) = 0.27 +/- 0.01, n = 8). Opposite effects of exogenous VIP and noradrenaline were on the other hand observed in the atropinized and beta-blocked preparation. These results suggest that in the rat portal vein neuronal VIP and circulating adrenaline may be complementary in their antagonism of the alpha-adrenoceptor mediated increase in contractility.
外源性血管活性肠肽(VIP)通过一种完全独立于普萘洛尔阻断的β-肾上腺素能受体、培养基中的高钾离子以及外源性牛胰多肽、神经降压素和阿片类物质的机制,引起离体大鼠肠系膜-门静脉制备物中自发机械活动的浓度依赖性抑制。在阿托品和酚妥拉明阻断的制备物中,VIP的效价(pD2 = 7.52 ± 0.18,n = 6)比异丙肾上腺素高约30倍。异丙肾上腺素的抑制作用是通过对去甲肾上腺素具有低表观亲和力的β2型肾上腺素能受体介导的(内在活性(α) = 0.27 ± 0.01,n = 8)。另一方面,在阿托品化和β阻断的制备物中观察到外源性VIP和去甲肾上腺素的相反作用。这些结果表明,在大鼠门静脉中,神经元性VIP和循环肾上腺素在拮抗α-肾上腺素能受体介导的收缩性增加方面可能具有互补作用。